“…Yes No 4 (6) Too many and abnormal centrosomes Yes No 5 (7) Karyotypic or "genetic" instability Yes No 6 (8) Immortality in vitro and on transplantation Yes No 7 (9) Clonal origin Yes Yes 9 (10) Non-clonal karyotypes and phenotypes, including non-clonal onco-and tumor suppressor genes [Hansemann, 1890;Hansemann, 1897;Hauser, 1903;Hauschka, 1961;Bauer, 1963;Braun, 1969;Pitot, 1986]; 2 [Boveri, 1914;Bauer, 1963;Cairns, 1978;Pitot, 1986]; 3 [Busch, 1974;Augenlicht et al, 1987;Zhang et al, 1997;Duesberg et al, 1999;Rasnick and Duesberg, 1999]; 4 [Bauer, 1963;Caspersson et al, 1963;Busch, 1974;Rasnick and Duesberg, 1999]; 5 [Brinkley and Goepfert, 1998;Lingle et al, 1998;Pihan et al, 1998;Duesberg, 1999]; 6 [Bauer, 1963;Braun, 1969;DiPaolo, 1975;Nowell, 1976;Harnden and Taylor, 1979;Pitot, 1986;Sandberg, 1990;Heim and Mitelman, 1995;Duesberg et al, 1998;Heppner and Miller, 1998;Rasnick and Duesberg, 1999]; 7 [Levan and Biesele, 1958;Saksela and Moorhead, 1963;Hayflick, 1965;Cairns, 1978;Harris, 1995]; 8 [Foulds, 1965;…”